After decades of setbacks, Alzheimer’s drug development is expanding beyond anti-amyloids, with a record number of trials and ...

A study published in Cell Stem Cell reveals that some mutations in blood stem cells might help protect against late-onset ...

Participants who chose not to learn their results said it would place a burden on themselves and their family members. As ...

Smaller, shallow brain folds in the posteromedial cortex show greater thinning with age and Alzheimer’s disease, and their ...

It’s not always obvious which of the multitude of species of bacteria riding around in us should be classified as germs and ...

Have you or someone you love been diagnosed with Alzheimer’s disease? This clinical trial may be just what you.

INmune Bio's XPro shows promise in early AD despite missed endpoints. Click here to find out why I rate INMB stock is a Hold.

Pinpointing who will and won’t get Alzheimer’s disease is tricky for doctors, but new research suggests it may soon get ...

Mayo Clinic researchers have developed a new artificial intelligence (AI) tool that helps clinicians identify brain activity ...

A study published in Cell Stem Cell reveals that some mutations in blood stem cells might help protect against late-onset ...

Ambroxol chaperones GCase; in a previous study of people with Parkinson's disease, the drug led to increased GCase levels. It ...